Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-06-28T23:04:02.956Z Has data issue: false hasContentIssue false
  • English
  • Français

Fluoxetine versus sertraline and paroxetine in major depression: Tolerability and efficacy in patients with high and low baseline anxiety

Published online by Cambridge University Press:  16 April 2020

M. Fava ,
J.F. Rosenbaum ,
S.L. Hoog ,
R.G. Tepner ,
J.B. Kopp  and
M. Sayler
M. Fava
Affiliation:
Massachusetts General Hospital, Boston, MA02114
J.F. Rosenbaum
Affiliation:
Massachusetts General Hospital, Boston, MA02114
S.L. Hoog
Affiliation:
Eli Lilly and Company, Indianapolis, IN46285, USA
R.G. Tepner
Affiliation:
Eli Lilly and Company, Indianapolis, IN46285, USA
J.B. Kopp
Affiliation:
Eli Lilly and Company, Indianapolis, IN46285, USA
M. Sayler
Affiliation:
Eli Lilly and Company, Indianapolis, IN46285, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 269s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.